Search

Your search keyword '"Callegaro, Dagoberto"' showing total 16 results
Start Over Author "Callegaro, Dagoberto" Journal multiple sclerosis and related disorders
16 results on '"Callegaro, Dagoberto"'

2. A comparative study of visual outcome in patients with optic neuritis treated with five or seven days of intravenous corticosteroid treatment

Author

Silva, Guilherme Diogo, Terrim, Sara, Falcão, Fernando Cavalcantide Sá e Benevides, Falcão, Maria Alice Pimentel, Chaves, Cleuber Esteves, Apóstolos-Pereira, Samira, Fortini, Ida, Gonçalves, Márcia Rúbia Rodrigues, Comerlatti, Luiz Roberto, Castro, Luiz Henrique Martins, Callegaro, Dagoberto, and Monteiro, Mário Luiz Ribeiro

Published
2023
Full Text
View/download PDF

9. Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges

Author

Marin, Cássia Elisa, Kfouri, Paula Prado, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurélio, Neto, Antonio Pereira Gomes, Vasconcelos, Claudia Cristina Ferreira, d'Almeida, José Artur Costa, Gonçalves, Marcus Vinícius Magno, Mendes, Maria Fernanda, Parolin, Mônica Koncke Fiuza, Nascimento, Osvaldo, da Gama, Paulo Diniz, Dias-Carneiro, Rafael Paternò Castello, Dias, Ronaldo Maciel, Damasceno, Alfredo, San Martin, Gustavo, and Becker, Jefferson

Published
2021
Full Text
View/download PDF

10. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Author

Whittam, Daniel H, Cobo-Calvo, Alvaro, Lopez-Chiriboga, A Sebastian, Pardo, Santiago, Gornall, Matthew, Cicconi, Silvia, Brandt, Alexander, Berek, Klaus, Berger, Thomas, Jelcic, Ilijas, Gombolay, Grace, Oliveira, Luana Micheli, Callegaro, Dagoberto, Kaneko, Kimihiko, Misu, Tatsuro, Capobianco, Marco, Gibbons, Emily, Karthikeayan, Venkatraman, Brochet, Bruno, Audoin, Bertrand, Mathey, Guillaume, Laplaud, David, Thouvenot, Eric, Cohen, Mikaël, Tourbah, Ayman, Maillart, Elisabeth, Ciron, Jonathan, Deschamps, Romain, Biotti, Damien, Rostasy, Kevin, Neuteboom, Rinze, Hemingway, Cheryl, Forsyth, Rob, Matiello, Marcelo, Webb, Stewart, Hunt, David, Murray, Katy, Hacohen, Yael, Lim, Ming, Leite, M Isabel, Palace, Jacqueline, Solomon, Tom, Lutterotti, Andreas, Fujihara, Kazuo, Nakashima, Ichiro, Bennett, Jeffrey L, Pandit, Lekha, Chitnis, Tanuja, Weinshenker, Brian G, Wildemann, Brigitte, Sato, Douglas Kazutoshi, Kim, Su-Hyun, Huda, Saif, Kim, Ho Jin, Reindl, Markus, Levy, Michael, Jarius, Sven, Tenembaum, Silvia, Paul, Friedemann, Pittock, Sean, Marignier, Romain, and Jacob, Anu

Published
2020
Full Text
View/download PDF

14. Vitamin D3as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials

Author

Mahler, João Vitor, Solti, Marina, Apóstolos-Pereira, Samira Luísa, Adoni, Tarso, Silva, Guilherme Diogo, and Callegaro, Dagoberto

Abstract

•We performed an updated systematic review and meta-analysis of randomized controlled trials of vitamin D3supplementation to evaluate its efficacy on multiple sclerosis related outcomes.•Vitamin D3as an add-on therapy to low-efficacy disease modifying drugs does not confer clinical or radiological benefits on timeframes lasting up to 24 months.•Additional studies are needed to explore outcomes over longer follow-up times.

Published
2024
Full Text
View/download PDF

15. Evaluation of myelin content in the spinal cord of patients with multiple sclerosis: a positron emission tomography study

Author

de Lucena, Letícia Zorante, Campanholo, Kenia Repiso, Pereira, Samira Luiza Apóstolos, Tavora, Daniel Gurgel Fernandes, Callegaro, Dagoberto, Buchpiguel, Carlos Alberto, Pitombeira, Milena Sales, and Faria, Daniele de Paula

Abstract

•PET imaging used to evaluate cervical spinal cord myelin content in people with MS•Lower [11C]PIB uptake in cervical spinal cord was associated with disability•[11C]PIB uptake could be used to assess demyelination in spinal cord

Published
2024
Full Text
View/download PDF

16. Vitamin D 3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.

Author

Mahler JV, Solti M, Apóstolos-Pereira SL, Adoni T, Silva GD, and Callegaro D

Subjects
Humans, Cholecalciferol therapeutic use, Randomized Controlled Trials as Topic, Disease Progression, Vitamin D, Multiple Sclerosis drug therapy, Vitamin D Deficiency
Abstract

Background: Vitamin D deficiency has been linked to a higher risk of multiple sclerosis (MS) and disease progression. However, the efficacy of vitamin D 3 as an adjuvant therapy for MS remains a controversial topic., Objective: To perform a systematic review and meta-analysis of randomized controlled trials to assess the impact of adjunct high-dose vitamin D 3 on clinical and radiological outcomes., Methods: PubMed, Embase, and Cochrane Library were searched for trials published until December 18th, 2022. Authors independently selected randomized controlled trials involving patients with MS, with an intervention group receiving high dose (≥ 1000 IU/day) cholecalciferol and reporting clinical or radiological outcomes. Authors independently extracted data and assessed the risk of bias using a standardized, pilot-tested form. The meta-analysis was conducted using RStudio for EDSS at the last follow-up, ARR, and new T2 lesion count., Results: We included 9 studies with 867 participants. No significant reduction of EDSS (MD = 0.02, CI 95 % [-0.37; 0.41], p = 0.91), ARR (MD -0.03, CI 95 % [-0.08; 0.02], p = 0.26), or new T2 lesions (MD -0.59, CI 95 % [-1.24;0.07], p = 0.08) was observed at 6-24 months. We found no evidence of publication bias., Conclusion: The findings of this meta-analysis strengthen current evidence that vitamin D 3 supplementation has no significant impact on clinical outcomes in patients with MS. However, the non-significant reduction of new T2 lesions could precede long-term clinical benefits and should be validated in additional studies., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Samira Luisa Apostolos Pereira reports a relationship with Biogen, Roche, Merck, Novartis, and EMS. that includes: funding grants. Tarso Adoni reports a relationship with Biogen, Roche, Merck, Novartis, and EMS. that includes:. Guilherme Diogo Silva reports a relationship with Biogen, Roche, Merck, Novartis, and EMS. that includes:. Dagoberto Callegaro reports a relationship with Biogen, Roche, Merck, Novartis, and EMS. that includes:., (Copyright © 2024 Elsevier B.V. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results